Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunogenicity of glycolipids.

× No keyword cloud information.

32 in total

1. An immunological model of epilepsy: seizures induced by antibodies to GM1 ganglioside.

Authors: S E Karpiak; S P Mahadik; L Graf; M M Rapport
Journal: Epilepsia Date: 1981-04 Impact factor: 5.864

2. Possible role of ceramide in defining structure and function of membrane glycolipids.

Authors: R Kannagi; E Nudelman; S Hakomori
Journal: Proc Natl Acad Sci U S A Date: 1982-06 Impact factor: 11.205

3. Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides.

Authors: Y Nagai; T Momoi; M Saito; E Mitsuzawa; S Ohtani
Journal: Neurosci Lett Date: 1976-04 Impact factor: 3.046

4. Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2.

Authors: E Nudelman; S Hakomori; R Kannagi; S Levery; M Y Yeh; K E Hellström; I Hellström
Journal: J Biol Chem Date: 1982-11-10 Impact factor: 5.157

5. Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients.

Authors: T Hirano; H Hashimoto; Y Shiokawa; M Iwamori; Y Nagai; M Kasai; Y Ochiai; K Okumura
Journal: J Clin Invest Date: 1980-12 Impact factor: 14.808

6. Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma.

Authors: G Ritter; E Ritter-Boosfeld; R Adluri; M Calves; S Ren; R K Yu; H F Oettgen; L J Old; P O Livingston
Journal: Int J Cancer Date: 1995-09-15 Impact factor: 7.396

7. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis.

Authors: A Pestronk; R N Adams; L Clawson; D Cornblath; R W Kuncl; D Griffin; D B Drachman
Journal: Neurology Date: 1988-09 Impact factor: 9.910

8. Characterization of the Hanganutziu-Deicher (serum-sickness) antigen as gangliosides containing n-glycolylneuraminic acid.

Authors: J M Merrick; K Zadarlik; F Milgrom
Journal: Int Arch Allergy Appl Immunol Date: 1978

9. Monoclonal antibody to galactosylceramide: discrimination of structural difference in the ceramide moiety.

Authors: H Nakakuma; M Arai; T Kawaguchi; K Horikawa; M Hidaka; K Sakamoto; M Iwamori; Y Nagai; K Takatsuki
Journal: FEBS Lett Date: 1989-12-04 Impact factor: 4.124

10. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.

Authors: N Yuki; M Yamada; S Sato; E Ohama; Y Kawase; F Ikuta; T Miyatake
Journal: Muscle Nerve Date: 1993-06 Impact factor: 3.217

4 in total

1. Effects of detergents on the redistribution of gangliosides and GPI-anchored proteins in brain tissue sections.

Authors: Marija Heffer-Lauc; Barbara Viljetić; Katarina Vajn; Ronald L Schnaar; Gordan Lauc
Journal: J Histochem Cytochem Date: 2007-04-04 Impact factor: 2.479

2. Aberrant glycosylation associated with enzymes as cancer biomarkers.

Authors: Danni L Meany; Daniel W Chan
Journal: Clin Proteomics Date: 2011-06-03 Impact factor: 3.988

3. Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells.

Authors: Ana Valeria Meléndez; Rubí M-H Velasco Cárdenas; Simon Lagies; Juliane Strietz; Lina Siukstaite; Oliver S Thomas; Jana Tomisch; Wilfried Weber; Bernd Kammerer; Winfried Römer; Susana Minguet
Journal: Cell Mol Life Sci Date: 2022-09-12 Impact factor: 9.207

4. CAM and NK Cells.

Authors: Kazuyoshi Takeda; Ko Okumura
Journal: Evid Based Complement Alternat Med Date: 2004-06-01 Impact factor: 2.629

4 in total